Submission Details
| 510(k) Number | K233421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 10, 2023 |
| Decision Date | March 08, 2024 |
| Days to Decision | 150 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K233421 is an FDA 510(k) clearance for the RESCAN 700, a Tomography, Optical Coherence (Class II — Special Controls, product code OBO), submitted by Carl Zeiss Meditec, AG (Jena, DE). The FDA issued a Cleared decision on March 8, 2024, 150 days after receiving the submission on October 10, 2023. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.1570.
| 510(k) Number | K233421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 10, 2023 |
| Decision Date | March 08, 2024 |
| Days to Decision | 150 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | OBO — Tomography, Optical Coherence |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.1570 |
| Definition | Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases. |